|
Age in years (median, IQR)
|
70 (64, 71)
|
65 (50, 71)
|
67.5 (54.5, 71)
|
|
Age > 65 years
|
4
|
3
|
7
|
|
Gender
| | | |
|
Male
|
5
|
5
|
10
|
|
Female
|
2
|
2
|
4
|
|
Ethnicity
| | | |
|
Chinese
|
4
|
6
|
10
|
|
Malay
|
1
|
0
|
1
|
|
Indian
|
1
|
1
|
2
|
|
Others
|
1
|
0
|
1
|
|
Charlson comorbidity score (median, IQR)
|
5 (4, 7)
|
5 (4, 8)
|
5 (4, 7)
|
|
Diabetes mellitus prior to screening
|
0
|
2
|
2
|
|
CKD prior to screening
|
3
|
2
|
5
|
|
Diabetes mellitus and CKD prior to screening
|
3
|
2
|
5
|
|
On vancomycin prior to study enrolment
|
5
|
7
|
12
|
|
Duration of vancomycin treatment prior to enrolment, days (median, IQR)
|
3 (3, 5)
|
4 (3, 5)
|
3.5 (3, 5)
|
|
On daptomycin prior to study enrolment
|
0
|
0
|
0
|
|
Diagnosis at enrolment
| | | |
|
Uncomplicated bacteremia
|
7
|
5
|
12
|
|
Complicated bacteremia without endocarditis
|
0
|
2
|
2
|
|
Endocarditis
|
0
|
0
|
0
|
|
Vancomycin MIC (median, IQR)
|
1.5 (1.5, 1.5)
|
1.5 (1.5, 1.5)
|
1.5 (1.5, 1.5)
|
